Prostein was described and characterized by Xu et al. as a prostate specific protein, which was quickly used by surgical pathologists for the differential diagnosis of prostate cancer, especially to rule out urothelial carcinoma, which is almost consistently prostein-negative [6,7,9,25,26]. This evidence concerns the gene SLC45A3 and prostate carcinoma.